Kallikreins and kinins: mediators in inflammatory joint disease?

No abstract is available for this paper.

• Publication year

  1990

• Venue

  International journal of experimental pathology (Print)

• Publication date

  1990-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 2205284PMCID PMC2002290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The possible role of neutrophil proteinases in damage to articular cartilage

  2005cited by this paper
• Depressed degranulation response of synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis to IgG aggregates

  1990cited by this paper
• A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis.

  1989cited by this paper
• Human neutrophils contain and bind high molecular weight kininogen.

  1989cited by this paper
• Development of bradykinin antagonists: structure-activity relationships for new categories of antagonist sequences.

  1989cited by this paper
• Tissue kallikrein effectively activates latent matrix degrading metalloenzymes.

  1989cited by this paper
• Identification of a tissue kallikrein in human polymorphonuclear leucocytes

  1989cited by this paper
• Kininogens, Kinins and Kinships

  1989cited by this paper
• Bradykinin stimulates tumor necrosis factor and interleukin‐1 release from macrophages

  1989cited by this paper
• The kallikrein-kininogen-kinin system in chronic inflammation

  1989cited by this paper
• Effect of urinary trypsin inhibitor on osteoarthritis.

  1988cited by this paper
• Inactivation of alpha‐1‐proteinase inhibitor in serum by stimulated human polymorphonuclear leucocytes. Evidence for a myeloperoxidase‐dependent mechanism

  1988cited by this paper
• Carboxypeptidase N (kininase I) activity in blood and synovial fluid from patients with arthritis.

  1987cited by this paper
• The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.

  1987cited by this paper
• The coagulation-kinin pathway of human plasma.

  1987cited by this paper
• Kallikrein in synovial fluid with rheumatoid arthritis.

  1987cited by this paper
• Assessment of kininases in rheumatic diseases and the effect of therapeutic agents.

  1987cited by this paper
• Kinins and bone resorption in rheumatic disease.

  1987cited by this paper
• Bradykinin, a new potential mediator of inflammation-induced bone resorption. Studies of the effects on mouse calvarial bones and articular cartilage in vitro.

  1987cited by this paper
• Long-term followup of rheumatoid arthritis patients treated with total lymphoid irradiation.

  1987cited by this paper
• Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.

  1987cited by this paper
• A synovial amidase acting on tissue kallikrein-selective substrate in clinical and experimental arthritis.

  1986cited by this paper
• Effects of heparin, histamine, and salmon calcitonin on mouse calvarial bone resorption.

  1986cited by this paper
• The Design of Substrate Analogue Tissue Kallikrein Inhibitors

  1986cited by this paper
• Stimulation of bone resorption in cultured mouse calvaria by Lys-bradykinin (kallidin), a potential mediator of bone resorption linking anaphylaxis processes to rarefying osteitis.

  1986cited by this paper
• Proliferative responses of T-cell lines grown from joint fluids of patients with rheumatoid arthritis and other arthritides.

  1986cited by this paper
• Alpha 2-macroglobulin-proteinase complexes as correlated with alpha 1-proteinase inhibitor-elastase complexes in synovial fluids of rheumatoid arthritis patients.

  1986cited by this paper
• Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors

  1986cited by this paper
• Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans.

  1985cited by this paper
• Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide.

  1985cited by this paper
• Mechanism of Action of Angiotensin II and Bradykinin on Prostaglandin Synthesis and Vascular Tone in the Isolated Rat Kidney: Effect of Ca++ Antagonists and Calmodulin Inhibitors

  1985cited by this paper
• Bradykinin stimulates bone resorption and lysosomal-enzyme release in cultured mouse calvaria.

  1984cited by this paper
• Osteoarthritis: are we asking the wrong questions?

  1984cited by this paper
• Synovial protease/inhibitor ratios in erosive and nonerosive arthropathies.

  1984cited by this paper
• Mast cells at sites of cartilage erosion in the rheumatoid joint.

  1984cited by this paper
• Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.

  1984cited by this paper
• Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse.

  1984cited by this paper
• Articular mastocytosis in rheumatoid arthritis.

  1984cited by this paper
• Human plasma kallikrein releases neutrophil elastase during blood coagulation.

  1983cited by this paper
• Plasma protein binding by monosodium urate crystals. Analysis by two-dimensional gel electrophoresis.

  1983cited by this paper
• Pharmacology of bradykinin and related kinins.

  1983cited by this paper
• Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid.

  1982cited by this paper
• The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein.

  1982cited by this paper
• Purified human plasma kallikrein aggregates human blood neutrophils.

  1982cited by this paper
• Progressive inhibition of human glandular (urinary) kallikrein by human serum and identification of the progressive antikallikrein as alpha 1-antitrypsin (alpha 1-protease inhibitor).

  1981cited by this paper
• Protease inhibitors in inflammatory synovial effusions.

  1981cited by this paper
• Antitrypsin activity and enzyme inhibitors in the rheumatoid joint.

  1981cited by this paper
• Pharmacology of bradykinin and related kinins.

  1980cited by this paper
• Kallikreins (kininogenases)--a group of serine proteases with bioregulatory actions.

  1979cited by this paper
• The synovial changes in post-traumatic synovitis and osteoarthritis.

  1978cited by this paper
• Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation.

  1977cited by this paper
• Absence of binding of pancreatic and urinary kallikreins to alpha 2-macroglobulin.

  1976cited by this paper
• The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.

  1976cited by this paper
• Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.

  1976cited by this paper
• Formation of human plasma kinin.

  1974cited by this paper
• PROSTAGLANDINS, KININ AND INFLAMMATION IN THE RAT

  1974cited by this paper
• The immunopathology of joint inflammation in rheumatoid arthritis.

  1973cited by this paper
• Demonstration of a kinin-generating enzyme in the lysosomes of human polymorphonuclear leukocytes.

  1973cited by this paper
• Kinin-converting aminopeptidase from human serum.

  1973cited by this paper
• Prostaglandins, aspirin-like drugs and analgesia.

  1972cited by this paper
• A PREALBUMIN ACTIVATOR OF PREKALLIKREIN

  1972cited by this paper
• Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

  1970cited by this paper
• Plasma kinins in synovial exudates.

  1970cited by this paper
• HUMAN PLASMA ALPHA 2-MACROGLOBULIN

  1970cited by this paper
• Anti-inflammatory effect of the trypsin-kallikrein inhibitor in acute arthritis induced by urate crystals in rabbits.

  1970cited by this paper
• THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR

  1969cited by this paper
• Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases. Origin and relation to disease category.

  1969cited by this paper
• A radioimmunoassay for bradykinin in plasma and synovial fluid.

  1969cited by this paper
• The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies.

  1967cited by this paper
• Observations on sheep with polyarthritis produced by an agent of the psittacosis-lymphogranuloma venereum-trachoma group.

  1967cited by this paper
• Urates and Kinin Formation in Synovial Fluid

  1966cited by this paper
• CARBOXYPEPTIDASE IN BLOOD AND OTHER FLUIDS. VALUES IN HUMAN BLOOD IN NORMAL AND PATHOLOGICAL CONDITIONS.

  1965cited by this paper
• THE INFLAMMATORY PROCESS IN ACUTE GOUTY ARTHRITIS. I. ACTIVATION OF HAGEMAN FACTOR BY SODIUM URATE CRYSTALS.

  1965cited by this paper
• Release of kinin by an enzyme in the accessory sex glands of the guinea‐pig

  1962cited by this paper
• Pain‐producing substance in human inflammatory exudates and plasma

  1957cited by this paper

• An Extensive Study of the Functional Polymorphisms of Kinin-Kallikrein System in Rheumatoid Arthritis Susceptibility.

  2018cites this paper
• Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.

  2014cites this paper
• IL‐4 and IL‐13 inhibit IL‐1β and TNF‐α induced kinin B1 and B2 receptors through a STAT6‐dependent mechanism

  2013cites this paper
• Peptide aldehyde inhibitors of the kallikreins: an investigation of subsite interactions with tripeptides containing structural variations at the amino terminus.

  2009cites this paper
• High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis

  2007cites this paper
• Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.

  2007cites this paper
• Inhibition of DNA Synthesis and Growth in Human Breast Stromal Cells by Bradykinin : Evidence for Independent Roles of BI and B 2 Receptors in the Respective Control of Cell Growth and Phospholipid Hydrolysis 1

  2006cites this paper
• Kinins : important regulators in inflammation induced bone resorption

  2006cites this paper
• Stimulated human neutrophils form biologically active kinin peptides from high and low molecular weight kininogens

  2004cites this paper
• Kallikreins and kininogens in saliva and plasma of patients presenting with rheumatoid arthritis

  2002cites this paper
• Kallikrein cascade and cytokines in inflamed joints.

  2002cites this paper
• Activities of plasminogen activator, plasmin and kallikrein in synovial fluid from patients with temporomandibular joint disorders.

  2001cites this paper
• Human tissue kallikrein S1 subsite recognition of non-natural basic amino acids.

  2001cites this paper
• Expression of Tissue Kallikrein and Kinin Receptors in Angiogenic Microvascular Endothelial Cells

  2000cites this paper
• Roles of the P1, P2, and P3 Residues in Determining Inhibitory Specificity of Kallistatin toward Human Tissue Kallikrein*

  2000cites this paper
• Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.

  1999cites this paper
• Crystal structure of recombinant human tissue kallikrein at 2.0 Å resolution

  1998cites this paper
• Rapid Direct Determination of Low and High Molecular Weight Kininogen in Human Plasma by Particle Concentration Fluorescence Immunoassay (PCFIA)

  1997cites this paper
• Generation of kinins in synovial fluid from patients with arthropathy.

  1997cites this paper
• Purification, Properties, and N-Terminal Amino Acid Sequence of a Kallikrein-like Enzyme from the Venom of Lachesis muta rhombeata (Bushmaster)

  1997cites this paper
• The Role of the Kallikrein—Kinin System in Inflammation-induced Bone Metabolism

  1997cites this paper
• The Molecular Biology of the Kallikreins and their Roles in Inflammation

  1997cites this paper
• Bradykinin stimulation does not induce intracellular Ca2+ elevation in cells from desmoid tumors.

  1996cites this paper
• Augmented plasma and tissue kallikrein like activity in synovial fluid of patients with inflammatory articular diseases

  1996cites this paper
• Kinetic mechanism of the inhibition of human urinary kallikrein by basic pancreatic trypsin inhibitor.

  1995cites this paper
• Complexes of tissue kallikrein with protein C inhibitor in human semen and urine.

  1995cites this paper
• An ultrasensitive chemiluminoenzyme immunoassay for the quantification of human tissue kininogens: application to synovial membrane and cartilage.

  1994cites this paper
• Prostatic kallikreins: biochemistry and physiology

  1994cites this paper
• Immunolocalization of renal kallikrein-like substance in rat urinary bladder

  1993cites this paper
• Post-translational processing of regulatory peptides

  1993cites this paper
• Tissue kallikreins and prostatic diseases in man: new questions.

  1992cites this paper
• Bioregulation of kinins: kallikreins, kininogens, and kininases.

  1992cites this paper
• Inhibition of DNA synthesis and growth in human breast stromal cells by bradykinin: evidence for independent roles of B1 and B2 receptors in the respective control of cell growth and phospholipid hydrolysis.

  1992cites this paper
• Linkage between blood coagulation and inflammation: stimulation of neutrophil tissue kallikrein by thrombin.

  1991cites this paper